Cargando…
Recent technological updates and clinical applications of induced pluripotent stem cells
Induced pluripotent stem cells (iPSCs) were first described in 2006 and have since emerged as a promising cell source for clinical applications. The rapid progression in iPSC technology is still ongoing and directed toward increasing the efficacy of iPSC production and reducing the immunogenic and t...
Autores principales: | Diecke, Sebastian, Jung, Seung Min, Lee, Jaecheol, Ju, Ji Hyeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164716/ https://www.ncbi.nlm.nih.gov/pubmed/25228828 http://dx.doi.org/10.3904/kjim.2014.29.5.547 |
Ejemplares similares
-
Generation of Functional Cardiomyocytes from the Synoviocytes of Patients with Rheumatoid Arthritis via Induced Pluripotent Stem Cells
por: Lee, Jaecheol, et al.
Publicado: (2016) -
Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis
por: Lee, Jaecheol, et al.
Publicado: (2014) -
Technological Progress in Generation of Induced Pluripotent Stem Cells for Clinical Applications
por: Oh, Seung-Ick, et al.
Publicado: (2012) -
Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders
por: Wattanapanitch, Methichit
Publicado: (2019) -
Recent updates of stem cell-based erythropoiesis
por: Han, Heeju, et al.
Publicado: (2023)